Research study Program year 2023 Source: CMS Open Payments

Ocrelizumab in PPMS

Research payments

$3,282,462

1,125 payments

Through program year 2023, $3,282,462 in research payments was reported against Ocrelizumab in PPMS, across 1,125 payments.

Paid by (largest first)
Roche Products Limited; Hoffmann-La Roche Limited
ClinicalTrials.gov
No trial number was reported for this study

By program year

5 rows
Year Kind Amount Payments
2023 Research $989 5
2022 Research $1,008,451 301
2021 Research $655,337 267
2020 Research $757,321 248
2019 Research $860,364 304

Breakdown

Who paid Research payments · program years 2019–2023
  1. Roche Products Limited $3,281,473 1,120 payments
  2. Hoffmann-La Roche Limited $989 5 payments
Who received the money Research payments · program years 2019–2023
  1. Langley Porter Psychiatric Hospital Teaching hospital · CA $863,062 126 payments
  2. Glendale Neurological Associates Pc Michigan Institute For Neurological Disorders Organisation paid for research $174,221 87 payments
  3. Geodyssey Research LLC Organisation paid for research $162,230 247 payments
  4. Atrium Health Cabarrus Teaching hospital · NC $155,393 52 payments
  5. University Of Colorado Denver Organisation paid for research $129,657 15 payments
  6. University Of Miami Organisation paid for research $121,445 24 payments
  7. The University of New Mexico Organisation paid for research $116,818 43 payments
  8. Hospital Of The Univ Of Penna Teaching hospital · PA $110,322 19 payments
  9. Washington University At St Louis Organisation paid for research $97,470 34 payments
  10. Wayne State University School O Organisation paid for research $95,419 18 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record